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DThis study, despite being a prospective analysis of
consecutive patients, is limited by the fact that it reflects
data from a single institution. The generalizability of these
findings to other national and international centers will
require a prospective multicenter study.
In summary, identification and correction of residual le-
sions in the operating room is associated with improved out-
comes. Enhanced intraoperative imaging, which can
provide information on all aspects of a repair, is an impor-
tant factor in achieving optimal surgical results before exit-
ing the operating room.References
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Dr Emile Bacha (New York, NY). Meena, a very nice presenta-
tion. It is very rare in heart surgery that one can confirm a so-called
dogma, so it is nice when you see that happening. Here you are
confirming, in a prospective manner no less, that a good or optimal
procedure achieved during the first bypass run achieves the best
possible results. You also showed that intraoperative recognition
and repair of residual defects is superior in terms of outcomes to
postoperative recognition and repair. I do not think anybody will
argue with your findings, but it is still nice to see them proven
scientifically. Your findings were particularly true for premature
neonates and young infants and for higher risk categories.
Although your study was focused more on the intraoperative
versus postoperative group, that is, the patients who underwent
re-repair during the first operation compared with the second oper-
ation, I was really interested in the comparison you had between
the NO group, no re-repair, versus the intraoperative group,gery c December 2014
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Dbecause you could look at the data differently. You had a higher
mortality in the intraoperative re-repair group versus the NO group
even though you had the same length of hospital stay, but that may
be determined by the patients who died and therefore you had a
lower length of hospital stay. I always tended to think about these
patients, those who undergo an immediate re-repair, as being equal
in terms of prognosis to those who had a first excellent repair.
Could you comment on that, please?
Dr Nathan. I need to mention that the NO group included
patients who underwent repair on cardiopulmonary bypass and
those who had non–cardiopulmonary bypass procedures such as
shunts and unifocalization, and the NO group had a much lower
rate of adverse events and mortality because they represented the
larger group of patients among the entire cohort. If we compared
just the patients who had undergone operations on cardiopulmo-
nary bypass, the difference would probably be much lower, and
we are in the process of analyzing that data.
Dr Bacha. So you are saying the groups are not well matched?
Dr Nathan. Not adequately matched, yes.
Dr Bacha.Another surgical dogma is that the enemy of good is
better, and that is one of the most difficult things a surgeon has to
decide in the operating room. If you have, let’s say, a mild or
moderate defect but your patient is doing okay, do you go back
on bypass and fix it versus do you accept it? That is a very difficult
decision to make. Can your data help us decide, maybe from what
you know on the technical performance score database, on that
particular question?
Dr Nathan. I totally agree with you that the enemy of good is
better, and we are actually in the process of developing a score
that will help us determine which residual lesions need revision
in the operating room versus those that can be followed. Most
postoperative revisions were related to valves, and I think this is
a group that needs to be studied individually rather than as part
of a large cohort. We are in the process of collecting and analyzing
data from this group of patients.
Dr Bacha. The third question is regarding the issue of timing of
the diagnosis of the residual defect, because I think it makes a
difference whether you are reoperating the next day for a major
residual defect versus 2 weeks or before discharge, let’s say. Do
you have any comments on the timing? Was that a factor?
Dr Nathan. The numbers are fairly small, so we could not look
at each individual time point of reintervention, but most of the
postoperative revisions were more than 48 hours after surgery.
Dr Bacha. Did that make a difference?
Dr Nathan.We have not looked at that specifically because the
numbers were too small to do a meaningful analysis.
Dr Bacha. And the last question. The most common type of re-
repair was a left AV valve repair. You would expect that, especially
if you have a large valve practice. Now, you could argue that if you
are doing complex leftAVvalve repairs, sometimes you simply have
to come off bypass, look at your TEE, and then go back on bypass
almost in a planned manner. Those were counted as re-repairs.
Do you think you should differentiate between valve re-repairs
versus nonvalve re-repairs such as residual aortic arch
obstructions, or residual VSDs that may potentially carry a worse
prognosis?
Dr Nathan. Thank you very much. I think that is really worth
exploring and we will proceed to do so.The Journal of Thoracic and CarDr Christian Pizarro (Wilmington, Del). Meena, a great
presentation and very interesting study. I wonder if you had the
opportunity to look at the use of extracorporeal membrane
oxygenation (ECMO) in those patients who had residual lesions
who were intervened on postoperatively? Not infrequently some-
times there are some of those lesions, the circulation is precarious,
and patients are not in good condition. Did you explore about how
that use of ECMO early with a plan to go to the operating room,
let’s say, the next day or so could have affected the outcome?
Dr Nathan. We did look at ECMO, but it was included as a
composite in the adverse events, because, again, the numbers in
each of the groups were small so that comparison using an
individual adverse event was difficult.
Dr Pizarro. And then just briefly, among those patients who
had a postoperative intervention, howmany of those had a residual
lesion that was identified in the operating room but deemed
probably not to be important enough? That goes to the judgment
at the time, should I leave this, should I act on it?
Dr Nathan. Among the valve repairs, at least on intraoperative
assessment, the regurgitation was usually at least a grade or two
lower than in later postoperative echocardiograms, so those could
not be picked up intraoperatively. Thus several valve repairs that
occurred postoperatively had an increase in grade of regurgitation
that necessitated their repair.
Dr Mark Danton (Glasgow, Scotland, UK). From your data,
obviously it is best to repair any residual lesion at the time of
the first operation. So with respect to the residual lesions that
required repair at a second or subsequent operation, were those
new lesions, first identified in the postoperative phase, or were
they lesions recognized at initial surgery but progressed over
time, or finally was the gravity of lesion underappreciated at the
time of intraoperative assessment. If it were the case that the
significance of the residual lesion was underestimated at surgery,
is there a better way of identifying them and their significance at
the first operation so that you do not have to deal with them at a
subsequent operation?
Dr Nathan. A small percentage of the valve re-repairs postopera-
tively were related to an increase in regurgitation grade related to
either a torn stitch or new additional regurgitation that was not identi-
fied in the operating room.So I think intraoperative assessment should
not only include a good echo, it should also include clinical assess-
ment, which is what all of us do in the operating room. And we are
in the process of trying to define the intraoperative echo findings
that match the postoperative echo findings that will identify which
intraoperative echo findings require a revision. We are currently in
the process of comparing intraoperative echos to postoperative echos
to arrive at cut points that will define better whenwe should intervene
in the operating room compared with postoperatively.
Dr Matthias Siepe (Freiburg, Germany). Excellent study.
Thank you. I am a little bit confused about those patients who
required a catheter-based intervention. In which group did you
put those patients? Or should there be a fifth group with
catheter-based reinterventions?
Dr Nathan. Currently these patients are included in the
postoperative revisions, because some of the patients did require
postoperative pulmonary artery stenting or dilation. The numbers
are fairly small, but wewill try and analyze that group as a separate
group and see if there is a difference.diovascular Surgery c Volume 148, Number 6 2547
